- Home
- GERN vs NRDS Comparison
GERN vs NRDS Comparison
Compare GERN & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- NRDS
- Stock Information
- Founded
- GERN 1990
- NRDS 2009
- Country
- GERN United States
- NRDS United States
- Employees
- GERN N/A
- NRDS N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- NRDS EDP Services
- Sector
- GERN Health Care
- NRDS Technology
- Exchange
- GERN Nasdaq
- NRDS Nasdaq
- Market Cap
- GERN 974.5M
- NRDS 810.0M
- IPO Year
- GERN 1996
- NRDS 2021
- Fundamental
- Price
- GERN $1.32
- NRDS $10.59
- Analyst Decision
- GERN Buy
- NRDS Buy
- Analyst Count
- GERN 8
- NRDS 6
- Target Price
- GERN $3.71
- NRDS $15.17
- AVG Volume (30 Days)
- GERN 9.4M
- NRDS 398.7K
- Earning Date
- GERN 08-07-2025
- NRDS 07-30-2025
- Dividend Yield
- GERN N/A
- NRDS N/A
- EPS Growth
- GERN N/A
- NRDS N/A
- EPS
- GERN N/A
- NRDS 0.38
- Revenue
- GERN $116,293,000.00
- NRDS $734,900,000.00
- Revenue This Year
- GERN $160.12
- NRDS $18.07
- Revenue Next Year
- GERN $55.01
- NRDS $8.22
- P/E Ratio
- GERN N/A
- NRDS $28.03
- Revenue Growth
- GERN 22264.04
- NRDS 24.20
- 52 Week Low
- GERN $1.17
- NRDS $7.55
- 52 Week High
- GERN $5.06
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- GERN 40.66
- NRDS 42.52
- Support Level
- GERN $1.36
- NRDS $11.07
- Resistance Level
- GERN $1.48
- NRDS $11.49
- Average True Range (ATR)
- GERN 0.09
- NRDS 0.32
- MACD
- GERN -0.02
- NRDS -0.04
- Stochastic Oscillator
- GERN 7.41
- NRDS 13.19
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.